|
| 36813570 | JUUL and its 'Action Network' attempt to prevent a local flavour ban. | Tob Control | 2024 |
| 36812454 | <i>Alliance for Hippocratic Medicine v. FDA</i> - <i>Dobbs'</i>s Collateral Consequences for Pharmaceutical Regulation. | N Engl J Med | 2023 |
| 37517865 | International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. | Cytotherapy | 2023 |
| 37745838 | Synthetic Nicotine: Science, Global Legal Landscape, and Regulatory Considerations. | World Health Organ Tech Rep Ser | 2023 |
| 37097267 | An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies. | Cytotherapy | 2023 |
| 37227265 | Effects of "Tobacco Free" Language in Warning Labels on Perceptions of Electronic Cigarettes and Nicotine Pouches among Young Adult Men: A Randomized Trial. | Subst Use Misuse | 2023 |
| 35020981 | State Restrictions on Mifepristone Access - The Case for Federal Preemption. | N Engl J Med | 2022 |
| 35545453 | Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products. | Cytotherapy | 2022 |
| 36568649 | Mifepristone, preemption, and public health federalism. | J Law Biosci | 2022 |
| 35102412 | Off-Label Prescription of COVID-19 Vaccines in Children: Clinical, Ethical, and Legal Issues. | Pediatrics | 2022 |
| 33154067 | Switching stories: user testimonials on juul.com continue to contradict JUUL's switch â¿ cessation narrative. | Tob Control | 2021 |
| 34473535 | Broader Implications of Eliminating FDA Jurisdiction Over Execution Drugs. | Am J Public Health | 2021 |
| 34818475 | A Divisive Ruling on Devices - <i>Genus Medical Technologies v. FDA</i>. | N Engl J Med | 2021 |
| 34048692 | ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update. | Stem Cell Reports | 2021 |
| 31613694 | Right to Try Requests and Oncologists' Gatekeeping Obligations. | J Clin Oncol | 2020 |
| 33569177 | The promise of direct-to-consumer COVID-19 testing: ethical and regulatory issues. | J Law Biosci | 2020 |
| 32053132 | New Graphic Tobacco Warnings and the First Amendment. | JAMA Oncol | 2020 |
| 31689508 | A special exception for CBD in foods and supplements? | Drug Discov Today | 2020 |
| 33315254 | Realizing Present and Future Promise of DIY Biology and Medicine through a Trust Architecture. | Hastings Cent Rep | 2020 |
| 32943452 | Self-experimentation, ethics, and regulation of vaccines. | Science | 2020 |
| 32908674 | Regulatory flexibility for COVID-19 research. | J Law Biosci | 2020 |
| 30387874 | Food and drug administration's regulatory shift on direct-to-consumer genetic tests for cancer risk. | Cancer | 2019 |
| 31273115 | Regulating genetic biohacking. | Science | 2019 |
| 31544641 | Biomedical Citizen Science or Something Else? Reflections on Terms and Definitions. | Am J Bioeth | 2019 |
| 29271014 | Prevalence of Publicly Available Expanded Access Policies. | Clin Pharmacol Ther | 2018 |
| 30105394 | Promoting Patient Interests in Implementing the Federal Right to Try Act. | JAMA | 2018 |
| 29879366 | Anticipating Industry Arguments: The US Food and Drug Administration's Authority to Reduce Nicotine Levels in Cigarettes. | Public Health Rep | 2018 |
| 31143463 | Is it 'gene therapy'? | J Law Biosci | 2018 |
| 31143461 | The stem cell market and policy options: a call for clarity. | J Law Biosci | 2018 |
| 30636822 | Closing the Regulatory Gap for Synthetic Nicotine Products. | Boston Coll Law Rev | 2018 |
| 28141931 | The challenge of paying for cost-effective cures. | Am J Manag Care | 2017 |
| 26202382 | Compassionate use of experimental therapies: who should decide? | EMBO Mol Med | 2015 |
| 27774220 | Regulating drug promotion to promote the public health: a response to Bennett et al. | J Law Biosci | 2015 |
| 24535082 | 23andMe, the Food and Drug Administration, and the future of genetic testing. | JAMA Intern Med | 2014 |
| 25264589 | The strange allure of state "right-to-try" laws. | JAMA Intern Med | 2014 |
| 20229846 | From a constitutional right to a policy of exceptions: Abigail Alliance and the future of access to experimental therapy. | Yale J Health Policy Law Ethics | 2010 |
| 20485512 | Calculating the Attentional Orientation of an Unfamiliar Agent in Infancy. | Cogn Dev | 2008 |
| 17198282 | Establishing procedures for institutional oversight of stem cell research. | Acad Med | 2007 |
| 16154311 | 'She gave it her best shot right away': patient experiences of biomedical and patient-centered communication. | Patient Educ Couns | 2006 |
| 16293581 | A new era in the ethics of human embryonic stem cell research. | Stem Cells | 2005 |
| 15566435 | Patient-centered communication: do patients really prefer it? | J Gen Intern Med | 2004 |